Osteosarcoma · 3 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Doxorubicin monotherapy Variant #10 | — | R 1 293 | 21d | ~5.8 mo | ~19.0 mo | ~9 | ~R 11 639 PFS proxy · indirect | 7 |
MAPIE [COG AOST0331] Partial | — | — | — | — | — | — | — | — |
MAPifn [COG AOST0331] Partial | — | — | — | — | — | — | — | — |
3 of 3 regimens shown